Of 22 patients evaluated in the control group, one alloantibody with HPA-5b reactivity was detected. CONCLUSION: Patients receiving PRT-treated PLT concentrates did not demonstrate antibodies to neoantigens, suggesting that neoantigen formation is not a critical side effect of this pathogen reduction ...